ATE121723T1 - Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents
Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE121723T1 ATE121723T1 AT92400416T AT92400416T ATE121723T1 AT E121723 T1 ATE121723 T1 AT E121723T1 AT 92400416 T AT92400416 T AT 92400416T AT 92400416 T AT92400416 T AT 92400416T AT E121723 T1 ATE121723 T1 AT E121723T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- group
- phenylethanolamino
- image
- phenylethanolaminomethyltetralines
- Prior art date
Links
- 239000013067 intermediate product Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 150000002118 epoxides Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000002048 spasmolytic effect Effects 0.000 abstract 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91400415A EP0499755A1 (de) | 1991-02-18 | 1991-02-18 | Phenylethanolaminotetraline, Verfahren zu deren Herstellung, Zwischenprodukte davon und diese enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE121723T1 true ATE121723T1 (de) | 1995-05-15 |
Family
ID=8208546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92400416T ATE121723T1 (de) | 1991-02-18 | 1992-02-17 | Phenylethanolamino- und phenylethanolaminomethyltetraline, verfahren zu deren herstellung zwischenprodukte davon und diese enthaltende pharmazeutische zusammensetzungen. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US5210276A (de) |
| EP (2) | EP0499755A1 (de) |
| JP (1) | JPH0565254A (de) |
| AT (1) | ATE121723T1 (de) |
| AU (1) | AU650096B2 (de) |
| CA (1) | CA2061311A1 (de) |
| DE (1) | DE69202173T2 (de) |
| DK (1) | DK0500443T3 (de) |
| ES (1) | ES2074343T3 (de) |
| HU (1) | HU212268B (de) |
| IE (1) | IE67166B1 (de) |
| MX (1) | MX9200651A (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104567A (en) * | 1992-02-03 | 1997-03-18 | Fujisawa Pharmaceutical Co | Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| RU2152925C1 (ru) * | 1994-08-12 | 2000-07-20 | Эли Лилли Энд Компани | Производные аминобицикло[3.1.0]гексан-2,6-дикарбоновой кислоты и фармацевтическая композиция |
| ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
| JP3708624B2 (ja) * | 1996-03-27 | 2005-10-19 | キッセイ薬品工業株式会社 | 3,4−ジ置換フェニルエタノールアミノテトラリンカルボン酸誘導体 |
| US5808080A (en) * | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
| DE69711519T2 (de) | 1996-09-05 | 2002-10-31 | Eli Lilly And Co., Indianapolis | Carbazolanaloge als selektive beta3-adrenergische Agonisten |
| CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL79323A (en) * | 1985-07-10 | 1990-03-19 | Sanofi Sa | Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them |
| EP0277917A3 (de) * | 1987-02-04 | 1990-03-28 | Ciba-Geigy Ag | Bestimmte Derivate von Adenosin-5'-carboxamid |
| FR2643076B1 (fr) * | 1989-02-14 | 1991-06-21 | Midy Spa | Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline |
| DE3924365A1 (de) * | 1989-07-22 | 1991-01-24 | Boehringer Ingelheim Kg | 2-amino-7-carbamoyl-1,2,3,4- tetrahydronaphthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US5206428A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Tetrahydronaphthalene derivatives and preparation thereof |
| US5206418A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Amino-tetrahydronaphthalene derivatives |
-
1991
- 1991-02-18 EP EP91400415A patent/EP0499755A1/de not_active Withdrawn
-
1992
- 1992-02-17 EP EP92400416A patent/EP0500443B1/de not_active Expired - Lifetime
- 1992-02-17 DE DE69202173T patent/DE69202173T2/de not_active Expired - Fee Related
- 1992-02-17 DK DK92400416.1T patent/DK0500443T3/da active
- 1992-02-17 CA CA002061311A patent/CA2061311A1/en not_active Abandoned
- 1992-02-17 AT AT92400416T patent/ATE121723T1/de not_active IP Right Cessation
- 1992-02-17 MX MX9200651A patent/MX9200651A/es not_active IP Right Cessation
- 1992-02-17 ES ES92400416T patent/ES2074343T3/es not_active Expired - Lifetime
- 1992-02-17 HU HU9200475A patent/HU212268B/hu not_active IP Right Cessation
- 1992-02-17 IE IE920495A patent/IE67166B1/en not_active IP Right Cessation
- 1992-02-18 US US07/836,253 patent/US5210276A/en not_active Expired - Fee Related
- 1992-02-18 AU AU11017/92A patent/AU650096B2/en not_active Ceased
- 1992-02-18 JP JP4030888A patent/JPH0565254A/ja active Pending
-
1993
- 1993-02-02 US US08/012,388 patent/US5401879A/en not_active Expired - Fee Related
-
1994
- 1994-12-19 US US08/358,380 patent/US5449813A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0500443T3 (da) | 1995-09-04 |
| ES2074343T3 (es) | 1995-09-01 |
| US5401879A (en) | 1995-03-28 |
| EP0499755A1 (de) | 1992-08-26 |
| HU9200475D0 (en) | 1992-04-28 |
| AU1101792A (en) | 1992-08-20 |
| IE67166B1 (en) | 1996-03-06 |
| CA2061311A1 (en) | 1992-08-19 |
| US5449813A (en) | 1995-09-12 |
| HU212268B (en) | 1996-04-29 |
| MX9200651A (es) | 1993-12-31 |
| US5210276A (en) | 1993-05-11 |
| EP0500443A1 (de) | 1992-08-26 |
| AU650096B2 (en) | 1994-06-09 |
| IE920495A1 (en) | 1992-08-26 |
| DE69202173D1 (de) | 1995-06-01 |
| JPH0565254A (ja) | 1993-03-19 |
| EP0500443B1 (de) | 1995-04-26 |
| DE69202173T2 (de) | 1995-09-07 |
| HUT61718A (en) | 1993-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE158568T1 (de) | Verfahren zur herstellung von quaternären diestern | |
| ATE128458T1 (de) | Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE124047T1 (de) | Oxazolopyridinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen. | |
| IL66650A (en) | Dibenzoxepines and dibenzooxazepines,their preparation and pharmaceutical compositions containing them | |
| DE69128236D1 (de) | N-Acyl-2,3-benzodiazepin-Derivate, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung | |
| ATE74352T1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| DE59005254D1 (de) | 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel. | |
| ATE127452T1 (de) | Poly-4-aminopyrrole-2-carboxamide derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ATE170521T1 (de) | 1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika | |
| DE3774888D1 (de) | Dihydrobenzofuran- und chromancarboxamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als neuroleptica. | |
| DE69202173D1 (de) | Phenylethanolamino- und Phenylethanolaminomethyltetraline, Verfahren zu deren Herstellung Zwischenprodukte davon und diese enthaltende pharmazeutische Zusammensetzungen. | |
| MX9606665A (es) | Derivados de acido 3-amino-2-mercaptobenzoico y procesos para su preparacion. | |
| ATE108440T1 (de) | Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| ATE138571T1 (de) | Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus. | |
| DE3882438D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
| DE10399014I2 (de) | Aminderivate, Verfahren zu ihrer Herstellung und diese enthaltende Fungizide. | |
| DE3772104D1 (de) | 4(5)-substituierte imidazol-derivate und zwischenverbindungen und verfahren zu ihrer herstellung. | |
| ATE103921T1 (de) | 1-oxa-2-oxo-8-azaspiro(4,5>decan-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen daraus. | |
| DE69410359D1 (de) | Benzospiroalken-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| ATE50448T1 (de) | 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-o - verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| ATE107298T1 (de) | 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE68905363D1 (de) | Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| DE3851579D1 (de) | Cyclische Aminothioacetalamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| ATE70838T1 (de) | Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |